Patents by Inventor Normand J. Robichaud

Normand J. Robichaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7521190
    Abstract: The subject invention relates to nucleic acid sequences for detection of mutations in a PKD-1 or PKD-2 gene, as well as biomarkers for ADPKD. The invention further relates to methods for diagnosing ADPKD in an individual, and kits for performing the methods of the invention. The invention also provides a method for determining in an individual the presence or absence of a mutant PKD gene.
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: April 21, 2009
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey G. Jones, Aidan N. Hennigan, John A. Curran, Susan K. Allen, Normand J. Robichaud, Jing Wang, Kerry E. Flynn, Jorge A. Garcés, Christopher M. Palatucci, William K. Seltzer
  • Patent number: 7273701
    Abstract: The subject invention relates to nucleic acid sequences for detection of mutations in a PKD-1 or PKD-2 gene, as well as biomarkers for ADPKD. The invention further relates to methods for diagnosing ADPKD in an individual, and kits for performing the methods of the invention. The invention also provides a method for determining in an individual the presence or absence of a mutant PKD gene.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: September 25, 2007
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey G. Jones, Aidan N. Hennigan, John A. Curran, Susan K. Allen, Normand J. Robichaud, Jing Wang, Kerry E. Flynn, Jorge A. Garcés, Christopher M. Palatucci, William K. Seltzer
  • Patent number: 6951763
    Abstract: Methods of detecting antibodies to one or more glycosphingolipid(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached theron, and the glycosphingolipid(s) of interest linked to the solid-phase reactant by an amide bond between an amino group of the glycosphingolipid of interest and a carbonyl group attached to the solid-phase reactant. The methods of detecting antibodies to glycosphingolipid(s) of interest can be used in methods of diagnosing autoimmune diseases in an individual.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: October 4, 2005
    Assignee: Athena Diagnostics, Inc.
    Inventors: Normand J. Robichaud, Louis P. Kertiles
  • Patent number: 6916619
    Abstract: The subject invention relates to methods for detection of mutations in a PKD gene using DHPLC. The invention includes the following aspects: identification of PKD unique sites; design of PKD-specific primers; amplification of PKD-specific products; and analysis of PCR amplified products by DHPLC. The invention further relates to compositions such as identified unique sites and PKD-specific primers, and kits for performing the methods of the invention.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: July 12, 2005
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey George Jones, Aidan Noel Hennigan, John A. Curran, Susan Kimberly Allen, Normand J. Robichaud, Jing Wang, Kerry Ellen Flynn, Jorge A. Garcés, Christopher M. Palatucci
  • Patent number: 6824999
    Abstract: Methods of detecting antibodies to one or more ganglioside(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached thereon, and the ganglioside(s) of interest linked to the solid-phase reactant by an amide bond between an amino group of the ganglioside of interest and a carbonyl group attached to the solid-phase reactant. The methods of detecting antibodies to ganglioside(s) of interest can be used in methods of diagnosing neuropathies in an individual.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: November 30, 2004
    Assignee: Athena Diagnostics, Inc.
    Inventors: Normand J. Robichaud, Louis P. Kertiles
  • Publication number: 20030203413
    Abstract: Methods of detecting antibodies to one or more glycosphingolipid(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached theron, and the glycosphingolipid(s) of interest linked to the solid-phase reactant by an amide bond between an amino group of the glycosphingolipid of interest and a carbonyl group attached to the solid-phase reactant. The methods of detecting antibodies to glycosphingolipid(s) of interest can be used in methods of diagnosing autoimmune diseases in an individual.
    Type: Application
    Filed: June 10, 2003
    Publication date: October 30, 2003
    Applicant: Athena Diagnostics, Inc.
    Inventors: Normand J. Robichaud, Louis P. Kertiles
  • Publication number: 20030152936
    Abstract: The subject invention relates to methods for detection of mutations in a PKD gene using DHPLC. The invention includes the following aspects: identification of PKD unique sites; design of PKD-specific primers; amplification of PKD-specific products; and analysis of PCR amplified products by DHPLC. The invention further relates to compositions such as identified unique sites and PKD-specific primers, and kits for performing the methods of the invention.
    Type: Application
    Filed: February 26, 2002
    Publication date: August 14, 2003
    Applicant: Athena Diagnostics
    Inventors: Jeffrey George Jones, Aidan Noel Hennigan, John A. Curran, Susan Kimberly Allen, Normand J. Robichaud, Jing Wang, Kerry Ellen Flynn, Jorge A. Garces, Christopher M. Palatucci
  • Patent number: 6599756
    Abstract: Methods of detecting antibodies to one or more glycosphingolipid(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached thereon, and the glycosphingolipid(s) of interest linked to the solid-phase reactant by an amide bond between an amino group of the glycosphingolipid of interest and a carbonyl group attached to the solid-phase reactant. The methods of detecting antibodies to glycosphingolipid(s) of interest can be used in methods of diagnosing autoimmune diseases in an individual.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: July 29, 2003
    Assignee: Athena Diagnostics, Inc.
    Inventors: Normand J. Robichaud, Louis P. Kertiles